Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Covington
AstraZeneca
Boehringer Ingelheim
Fish and Richardson
Moodys
US Army
Deloitte

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020372

« Back to Dashboard

NDA 020372 describes MYOVIEW 30ML, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the MYOVIEW 30ML profile page.

The generic ingredient in MYOVIEW 30ML is technetium tc-99m tetrofosmin kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m tetrofosmin kit profile page.
Summary for 020372
Tradename:MYOVIEW 30ML
Applicant:Ge Healthcare
Ingredient:technetium tc-99m tetrofosmin kit
Patents:1
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020372
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MYOVIEW technetium tc-99m tetrofosmin kit INJECTABLE;INJECTION 020372 NDA Medi-Physics Inc. dba GE Healthcare 17156-026 N 17156-026-30
MYOVIEW 30ML technetium tc-99m tetrofosmin kit INJECTABLE;INJECTION 020372 NDA Medi-Physics Inc. dba GE Healthcare 17156-026 N 17156-026-30

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Feb 9, 1996TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthN/A
Approval Date:Jul 7, 2005TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Mar 10, 2030Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Healthtrust
Deloitte
US Army
Chubb
QuintilesIMS
AstraZeneca
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.